Fall Study in Gothenburg (FallsGOT)

NCT ID: NCT02264470

Last Updated: 2018-11-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

505 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-10-01

Study Completion Date

2016-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Falls after stroke are common. Previous research has shown that almost every other, 48%, of patients with a first-ever stroke fell at least once during the first year after stroke (1). Moreover, most of the patients fell during the first three months after stroke onset. However, the exact time-point for the falls was not analyzed (1). In addition, many patients are falling already during hospital stay (2-5). Reducing the number of falls during inpatient rehabilitation on a stroke unit is a high-priority mission. Greater knowledge concerning the factors that best predict falls is eligible.

The aim of the study is to analyze the significance of different physiological, psychological and medical factors for predicting the risk of falling in patients with stroke per day of care at a stroke unit.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Sample size assessment: According statistical consultation it is required to include at least 150 patients. The target figure is to include 500 patients. That number enables sub analyzes.

Inclusion criterion: All patients with clinical stroke (infarction as bleeding, first-time or recurrent) at the stroke unit 354 will be asked for study participation.

Exclusion criterion: Patients not willing to participate in the study.

The response variable is fall. A fall is defined as an event which results in a person coming to rest inadvertently on the ground or floor or other lower level. The definition of a fall refers to the World Health Organization (http://www.who.int/mediacentre/factsheets/fs344/en/ 2014-09-29). Data regarding falls will be collected from MedControl Pro (without any official possible expansions). MedControl Pro is a web based program for deviations. For validation of data concerning falls, assessment of medical journals will also be implemented.

The significance of the following covariates will be used in the analyses:

1. The patient's confidence in their own balance (postural control).

\- Do you feel that your balance (postural control) is impaired?
2. Fear of falling

\- Are you afraid to fall? (Fear of falling)
3. Postural control in everyday activities

* The modified version of the Postural Assessment Scale for Stroke Patients (SwePASS)
4. Postural control; tandem stance (A decisive moment?)

\- Do the patient manages tandem stance 30 s or not?/use of scale 0-4
5. Risk taking behaviour

* Is the patient inclined to take a risk in tandem stance?
6. Self reported previous physical activity (PA) level.

\- Grimby \& Saltin scale and/or 150 minutes of PA/week or not
7. Cognitive ability

\- Montreal Cognitive Assessment (MoCa)
8. Medication

\- Registration of drugs and their Anatomical Therapeutic Chemical (ATC) classification codes
9. Blood pressure

\- Blood pressure and pulse lying and after 1 and 3 minutes standing
10. The use of walking aids
11. The use of wheelchair
12. Age
13. Sex
14. Length of stay (in days) on the stroke unit.

In addition, the National Institutes of Health Stroke Scale (NIHSS) result will be registered and used to describe the study population.

Data collection:

Data collection will take place once, as fast as possible but at the latest 4 days after admission to the stroke unit. There are two exceptions:

First, data collection regarding drugs will take place day 4 after admission. However, in case of a fall before day 4 after admission, the data collection will be based on the drug list the current fall day.

Second, data concerning cognition using MoCA will be performed once sometime during the stroke-unit stay (due to organisation issues). That is, not at any particular time, but the greater the suspicion of cognitive impairment, the later during the stroke unit stay.

Statistical analysis:

The poisson regression analysis will be used in order to address number of falls (fall risk) per day and night at the stroke unit. Poisson regression takes into account the wide variation in length of stay at the stroke unit.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Accidental Falls

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with clinical stroke

All patients with stroke, 18 years or older, are asked for participation.

Not relevant

Intervention Type OTHER

Not relevant

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Not relevant

Not relevant

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with clinical stroke, whether first-ever or recurrent stroke and whether caused by cerebral infarction or cerebral hemorrhage
* Patients 18 years old or older

Exclusion Criterion:

* Patients unwilling to participate in the study.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Göteborg University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Carina U Persson, PhD

Role: STUDY_DIRECTOR

Göteborg University

Carina U Persson, PhD

Role: PRINCIPAL_INVESTIGATOR

Göteborg University

Carina U Persson, PhD

Role: STUDY_CHAIR

Göteborg University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sahlgrenska University Hospital/Östra

Gothenburg, Diagnosvägen 1, Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sweden

References

Explore related publications, articles, or registry entries linked to this study.

Schnitzer L, Hansson PO, Samuelsson CM, Drummond A, Persson CU. Fatigue in stroke survivors: a 5-year follow-up of the Fall study of Gothenburg. J Neurol. 2023 Oct;270(10):4812-4819. doi: 10.1007/s00415-023-11812-0. Epub 2023 Jun 15.

Reference Type DERIVED
PMID: 37318549 (View on PubMed)

Samuelsson CM, Hansson PO, Persson CU. Determinants of Recurrent Falls Poststroke: A 1-Year Follow-up of the Fall Study of Gothenburg. Arch Phys Med Rehabil. 2020 Sep;101(9):1541-1548. doi: 10.1016/j.apmr.2020.05.010. Epub 2020 Jun 1.

Reference Type DERIVED
PMID: 32497600 (View on PubMed)

Westerlind EK, Lernfelt B, Hansson PO, Persson CU. Drug Treatment, Postural Control, and Falls: An Observational Cohort Study of 504 Patients With Acute Stroke, the Fall Study of Gothenburg. Arch Phys Med Rehabil. 2019 Jul;100(7):1267-1273. doi: 10.1016/j.apmr.2018.12.018. Epub 2019 Jan 3.

Reference Type DERIVED
PMID: 30610872 (View on PubMed)

Laren A, Odqvist A, Hansson PO, Persson CU. Fear of falling in acute stroke: The Fall Study of Gothenburg (FallsGOT). Top Stroke Rehabil. 2018 May;25(4):256-260. doi: 10.1080/10749357.2018.1443876. Epub 2018 Mar 1.

Reference Type DERIVED
PMID: 29493399 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CUPersson

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.